MKTX Establishes Growth Goals for 2026-2028 and Increases Share Buyback Program
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2025
0mins
Source: NASDAQ.COM
Medium-Term Financial Objectives: MarketAxess Holdings Inc. has set medium-term financial targets aiming for 8-9% annual revenue growth and a 75-125 basis point improvement in operating margin from 2026 to 2028, based on stable market conditions and technology investments.
Share Repurchase Program: The company announced a share repurchase program totaling $505 million, which includes $400 million in new authorizations and $105 million from a previous program, with plans to finance it through cash reserves and borrowings.
Financial Position and Performance: MarketAxess reported strong financial health with $473.3 million in cash as of September 30, 2025, and a 6.9% increase in net cash from operations year-over-year, alongside a recent 2.7% dividend hike.
Stock Performance and Comparisons: MarketAxess shares have increased by 1% over the past month, underperforming the industry average of 2.1%, while other finance stocks like CB Financial and Acadian Asset Management have shown stronger gains.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EFC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EFC
Wall Street analysts forecast EFC stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.590
Low
14.50
Averages
15.00
High
16.00
Current: 13.590
Low
14.50
Averages
15.00
High
16.00
About EFC
Ellington Financial Inc. operates as a real estate investment trust (REIT). The Company acquires and manages mortgage-related, consumer-related, corporate-related, and other financial assets. Its segments include Investment Portfolio Segment and Longbridge Segment. The Investment Portfolio Segment invests in financial assets, including residential and commercial mortgage loans; residential mortgage-backed securities (RMBS); commercial mortgage-backed securities (CMBS); consumer loans and asset-backed securities (ABS) including ABS backed by consumer loans; investments referencing mortgage servicing rights on traditional forward mortgage loans; collateralized loan obligations; non-mortgage- and mortgage-related derivatives; debt and equity investments in loan origination companies; and other strategic investments. The Longbridge Segment is engaged in the business of originating, purchasing, selling and servicing reverse mortgage loans, including home equity conversion mortgage loans.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Delphi Financial Increases Stake in Ellington Financial
- Increased Stake: Delphi Financial acquired an additional 686,639 shares of Ellington Financial in Q1 2026, with an estimated transaction value of $8.73 million, demonstrating confidence in Ellington's future prospects and solidifying its position in the portfolio.
- Asset Management Proportion Rise: Following the increase, Ellington Financial now represents 7.53% of Delphi's 13F reportable AUM, indicating its sixth position in Delphi's investment portfolio and highlighting its significance in diversified investment strategies.
- Strong Financial Performance: Ellington Financial achieved record earnings in Q1 2026, with a net income of $146.87 million, indicating robust business fundamentals that continue to attract Delphi Financial's investment.
- Stable Dividend Payments: Ellington Financial has reliably issued monthly dividends since 2010, providing a stable cash flow that adds to the attractiveness of Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Delphi Increases Stake in Ellington Financial by $8.73 Million
- Increased Stake: Delphi Financial Group increased its stake in Ellington Financial by 686,639 shares in Q1 2026, with an estimated transaction value of $8.73 million, indicating strong confidence in Ellington's future prospects.
- Asset Allocation Shift: This acquisition raises Ellington Financial's representation in Delphi's 13F reportable AUM to 7.53%, moving it to the sixth-largest holding, reflecting its significance in a diversified investment portfolio.
- Strong Financial Performance: Ellington Financial reported record earnings in Q1 2026 with a net income of $146.87 million, demonstrating robust business fundamentals that continue to attract Delphi's investment.
- Stable Dividend Payments: Having issued monthly dividends since 2010, Ellington Financial's reliable cash flow adds extra appeal for Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Ellington Financial Reports Strong Q1 Earnings Exceeding Expectations
- Significant Revenue Growth: Ellington Financial reported Q1 revenues of $171.3 million, marking a 107% year-over-year increase and exceeding analyst expectations by 55.1%, showcasing the company's strong performance in managing mortgage-related assets and boosting investor confidence.
- Stock Price Recovery: Since the earnings report, Ellington Financial's stock has risen by 2.7%, currently trading at $13.47, reflecting a positive market reaction to its financial health, which may attract more investor interest.
- Mixed Industry Performance: Despite Ellington Financial's standout results, the overall 12 tracked thrifts and mortgage finance companies reported revenues just 4.1% above analyst expectations, indicating competitive pressures and market volatility affecting overall stock performance.
- Cautious Future Outlook: Although Ellington Financial performed strongly, its revenue guidance for the next quarter is 1.5% below expectations, potentially reflecting market uncertainties regarding future economic conditions, prompting investors to carefully assess potential risks.
See More
Ellington Financial Reports Strong Q1 2026 Earnings with Record Securitization
- Strong Financial Performance: Ellington Financial reported a GAAP net income of $0.78 per share for Q1 2026, a significant increase from $0.14 in Q4 2025, indicating a marked improvement in profitability that is expected to positively impact shareholder returns.
- Reverse Mortgage Innovation: Longbridge achieved near-record reverse mortgage loan origination volumes of $515 million this quarter, representing a 52% increase year-over-year, which not only enhances market share but also lays a solid foundation for future revenue growth.
- Record Securitization Scale: The company reached a record securitization volume of $2.8 billion this quarter, showcasing strong performance in capital markets that further enhances liquidity and financing capabilities.
- Optimistic Outlook: Management raised quarterly ADE guidance to $0.45 per share, while cautioning that Longbridge's contribution level should not be viewed as a new baseline, a strategy that will help the company maintain competitiveness amid future market fluctuations.
See More
Ellington Financial Declares $0.13 Monthly Dividend, Yield at 11.76%
- Dividend Declaration: Ellington Financial has declared a monthly dividend of $0.13 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flows and bolster investor confidence.
- Yield Performance: The forward yield stands at 11.76%, attracting income-seeking investors and reflecting the company's competitiveness in the current market environment, which is crucial for sustaining investor interest.
- Shareholder Arrangement: The dividend is payable on April 30, with a record date of March 31 and an ex-dividend date also set for March 31, ensuring shareholders receive timely returns and reinforcing the relationship between the company and its investors.
- Strategic Growth Goals: Ellington Financial aims to achieve further portfolio growth and liability optimization through expanded securitization and strategic acquisitions, indicating an aggressive expansion strategy in the market.
See More
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Delphi Financial Increases Stake in Ellington Financial
- Increased Stake: Delphi Financial acquired an additional 686,639 shares of Ellington Financial in Q1 2026, with an estimated transaction value of $8.73 million, demonstrating confidence in Ellington's future prospects and solidifying its position in the portfolio.
- Asset Management Proportion Rise: Following the increase, Ellington Financial now represents 7.53% of Delphi's 13F reportable AUM, indicating its sixth position in Delphi's investment portfolio and highlighting its significance in diversified investment strategies.
- Strong Financial Performance: Ellington Financial achieved record earnings in Q1 2026, with a net income of $146.87 million, indicating robust business fundamentals that continue to attract Delphi Financial's investment.
- Stable Dividend Payments: Ellington Financial has reliably issued monthly dividends since 2010, providing a stable cash flow that adds to the attractiveness of Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Delphi Increases Stake in Ellington Financial by $8.73 Million
- Increased Stake: Delphi Financial Group increased its stake in Ellington Financial by 686,639 shares in Q1 2026, with an estimated transaction value of $8.73 million, indicating strong confidence in Ellington's future prospects.
- Asset Allocation Shift: This acquisition raises Ellington Financial's representation in Delphi's 13F reportable AUM to 7.53%, moving it to the sixth-largest holding, reflecting its significance in a diversified investment portfolio.
- Strong Financial Performance: Ellington Financial reported record earnings in Q1 2026 with a net income of $146.87 million, demonstrating robust business fundamentals that continue to attract Delphi's investment.
- Stable Dividend Payments: Having issued monthly dividends since 2010, Ellington Financial's reliable cash flow adds extra appeal for Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Ellington Financial Reports Strong Q1 Earnings Exceeding Expectations
- Significant Revenue Growth: Ellington Financial reported Q1 revenues of $171.3 million, marking a 107% year-over-year increase and exceeding analyst expectations by 55.1%, showcasing the company's strong performance in managing mortgage-related assets and boosting investor confidence.
- Stock Price Recovery: Since the earnings report, Ellington Financial's stock has risen by 2.7%, currently trading at $13.47, reflecting a positive market reaction to its financial health, which may attract more investor interest.
- Mixed Industry Performance: Despite Ellington Financial's standout results, the overall 12 tracked thrifts and mortgage finance companies reported revenues just 4.1% above analyst expectations, indicating competitive pressures and market volatility affecting overall stock performance.
- Cautious Future Outlook: Although Ellington Financial performed strongly, its revenue guidance for the next quarter is 1.5% below expectations, potentially reflecting market uncertainties regarding future economic conditions, prompting investors to carefully assess potential risks.
See More
Ellington Financial Reports Strong Q1 2026 Earnings with Record Securitization
- Strong Financial Performance: Ellington Financial reported a GAAP net income of $0.78 per share for Q1 2026, a significant increase from $0.14 in Q4 2025, indicating a marked improvement in profitability that is expected to positively impact shareholder returns.
- Reverse Mortgage Innovation: Longbridge achieved near-record reverse mortgage loan origination volumes of $515 million this quarter, representing a 52% increase year-over-year, which not only enhances market share but also lays a solid foundation for future revenue growth.
- Record Securitization Scale: The company reached a record securitization volume of $2.8 billion this quarter, showcasing strong performance in capital markets that further enhances liquidity and financing capabilities.
- Optimistic Outlook: Management raised quarterly ADE guidance to $0.45 per share, while cautioning that Longbridge's contribution level should not be viewed as a new baseline, a strategy that will help the company maintain competitiveness amid future market fluctuations.
See More
Ellington Financial Declares $0.13 Monthly Dividend, Yield at 11.76%
- Dividend Declaration: Ellington Financial has declared a monthly dividend of $0.13 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flows and bolster investor confidence.
- Yield Performance: The forward yield stands at 11.76%, attracting income-seeking investors and reflecting the company's competitiveness in the current market environment, which is crucial for sustaining investor interest.
- Shareholder Arrangement: The dividend is payable on April 30, with a record date of March 31 and an ex-dividend date also set for March 31, ensuring shareholders receive timely returns and reinforcing the relationship between the company and its investors.
- Strategic Growth Goals: Ellington Financial aims to achieve further portfolio growth and liability optimization through expanded securitization and strategic acquisitions, indicating an aggressive expansion strategy in the market.
See More
